Trial in progress: clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401

R. Dummer; R. Gutzmer; P. Corrie; M. Millward; A. Murzhenko; M. Maio

Trial in progress: clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401

R. Dummer, R. Gutzmer, P. Corrie, M. Millward, A. Murzhenko, M. Maio

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	E43-E43
Number of pages	1
Journal	Melanoma Research
Volume	26
Publication status	Published - Aug 2016
Externally published	Yes

Cite this

@article{cd7c00f081314dee9e620bb3662b8f9f,

title = "Trial in progress: clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401",

author = "R. Dummer and R. Gutzmer and P. Corrie and M. Millward and A. Murzhenko and M. Maio",

year = "2016",

month = aug,

language = "English",

volume = "26",

pages = "E43--E43",

journal = "Melanoma Research",

issn = "0960-8931",

publisher = "Lippincott Williams & Wilkins",

}

Trial in progress: clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401. / Dummer, R.; Gutzmer, R.; Corrie, P. et al.
In: Melanoma Research, Vol. 26, 08.2016, p. E43-E43.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Trial in progress

T2 - clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401

AU - Dummer, R.

AU - Gutzmer, R.

AU - Corrie, P.

AU - Millward, M.

AU - Murzhenko, A.

AU - Maio, M.

PY - 2016/8

Y1 - 2016/8

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000383560800080&DestLinkType=FullRecord&DestApp=WOS

M3 - Abstract/Meeting Abstract

SN - 0960-8931

VL - 26

SP - E43-E43

JO - Melanoma Research

JF - Melanoma Research

ER -

Trial in progress: clinical trial of nivolumab combined with ipilimumab followed by nivolumab monotherapy as first-line therapy of patients with stage III (unresectable) or stage IV melanoma: CheckMate 401

Other files and links

Cite this